VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs PFE

PFE

In the past 12 months, ABBV returned +20% while PFE gained 16%.

ABBV
ABBV

AbbVie Inc.

$256.34
5.1%(1M)
Market Cap452.9B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio73.56
ROE-136.5%
P/B Ratio-77.91
Dividend Yield2.6%
PFE
PFE

Pfizer Inc.

$28.81
15.1%(1M)
Market Cap164.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio38.40
ROE4.9%
P/B Ratio1.94
Dividend Yield5.9%
Performance Comparison

Historical returns across multiple timeframes

ABBV leads 6/8
ABBV

ABBV

AbbVie Inc.

+20.3%

1Y Return

PFE

PFE

Pfizer Inc.

+16.2%

1Y Return

ABBV
ABBV
PFE
PFE

Short Term

1M-6M

PFE
+12.4%

Medium Term

YTD-1Y

ABBV
+16.3%

Long Term

3Y-10Y

ABBV
+169.1%

Valuation

Compare price multiples and valuation ratios

ABBV: 1PFE: 4
MetricABBVPFEWinner
P/E Ratio

Price to earnings ratio

73.5638.40PFE
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

7.162.60PFE
P/B Ratio

Price to book ratio

-77.911.94ABBV
P/FCF Ratio

Price to free cash flow ratio

23.4415.08PFE
EV/EBITDA

Enterprise value to EBITDA

24.6918.02PFE
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 5PFE: 1
MetricABBVPFEWinner
Gross Margin

Gross profit margin

71.5%71.3%ABBV
Operating Margin

Operating profit margin

29.3%25.1%ABBV
Net Margin

Net profit margin

9.8%6.8%ABBV
ROE

Return on equity

-136.5%4.9%PFE
ROA

Return on assets

4.7%2.2%ABBV
ROIC

Return on invested capital

13.5%9.3%ABBV

Growth

Compare revenue and earnings growth rates

ABBV: 5PFE: 1
MetricABBVPFEWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%-1.6%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%-14.6%ABBV
Revenue Growth (5Y)

5-year revenue CAGR

6.0%8.5%PFE
EPS Growth (YoY)

Year-over-year EPS growth

-0.8%-3.5%ABBV
EPS Growth (3Y)

3-year EPS CAGR

-29.0%-37.1%ABBV
EPS Growth (5Y)

5-year EPS CAGR

-2.7%-3.5%ABBV

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 2PFE: 2
MetricABBVPFEWinner
Debt/Equity

Debt to equity ratio

-11.930.74ABBV
Current Ratio

Current assets to current liabilities

0.811.27PFE
Quick Ratio

Quick assets to current liabilities

0.690.96PFE
Interest Coverage

EBIT to interest expense

6.475.92ABBV
Beta

Stock volatility vs market

0.280.28Tie
Summary
ABBV wins 2-1

Valuation

PFE

Profitability

ABBV

Growth

ABBV

Balance Sheet

Tie

PFE is more attractively valued. ABBV shows stronger profitability. ABBV demonstrates better growth.

Take Your Analysis Further

Dive deeper into ABBV and PFE with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/PFE" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs PFE on stockvs.app
</a>